HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of a randomized trial on maintenance tocolysis on length of hospital admission of women with threatened preterm labor in The Netherlands.

AbstractINTRODUCTION:
The APOSTEL-II trial was a multicenter randomized placebo-controlled trial, assessing the effectiveness of maintenance tocolysis with nifedipine. The trial showed maintenance tocolysis not to have an effect on perinatal outcome. Objective of the current study is to evaluate the effect of a negative trial on the length of hospital admission of women with threatened preterm labor.
MATERIALS AND METHODS:
We evaluated length of hospital admission of all patients admitted with threatened preterm labor with a gestational age <32 weeks in 8 perinatal centers that participated in the APOSTEL-II trial. We studied only the first admission with threatened preterm labor, readmissions were excluded. We distinguished between the period before, the period during and the period after the trial. In a subgroup analysis, we differentiated for the group of women who delivered and for the group of women who did not deliver during the initial admission.
RESULTS:
The mean length of hospital admission was 9.3 days before the start of the trial, 8.4 days during the recruitment period and 8.1 days after the trial was completed. The difference in mean length of hospital admission before and during the recruitment period was significantly different (p<001).
COMMENTS:
The length of hospital admission of women with threatened preterm labor is found to be reduced during the recruitment period of the APOSTEL-II trial. This shows that the conduct of a randomized controlled trial itself has the potential to change daily practice.
AuthorsThomas S de Lange, Carolien Roos, Kitty W M Bloemenkamp, Antoinette C Bolte, Johannes J J Duvekot, Maureen T M Franssen, Marjolein Kok, Martijn A Oudijk, Martina M Porath, Joris A M van der Post, Ben Willem J Mol
JournalEuropean journal of obstetrics, gynecology, and reproductive biology (Eur J Obstet Gynecol Reprod Biol) Vol. 186 Pg. 8-11 (Mar 2015) ISSN: 1872-7654 [Electronic] Ireland
PMID25596476 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Tocolytic Agents
  • Nifedipine
Topics
  • Female
  • Gestational Age
  • Humans
  • Length of Stay (trends)
  • Netherlands
  • Nifedipine (therapeutic use)
  • Obstetric Labor, Premature (prevention & control)
  • Pregnancy
  • Retrospective Studies
  • Tocolytic Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: